Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Phase: N/A Priority: Normal
NCT ID: NCT01514227 Org: User:
Start: 12/31/11 End: 06/30/16 Due: 06/30/17

Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01325935 Org: User:
Start: 04/30/11 End: 12/31/13 Due: 12/31/14

Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect

Phase: N/A Priority: Normal
NCT ID: NCT02002910 Org: User:
Start: 10/31/13 End: 09/30/16 Due: 09/30/17

Japan-Drug Eluting Stents Evaluation; a Randomized Trial

Phase: N/A Priority: Normal
NCT ID: NCT00708669 Org: User:
Start: 03/31/08 End: - Due: -

Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation Stents

Phase: N/A Priority: Normal
NCT ID: NCT01256723 Org: User:
Start: 10/31/10 End: 05/31/18 Due: 05/31/19

A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)

Phase: N/A Priority: Normal
NCT ID: NCT01808391 Org: User:
Start: 03/31/13 End: 04/30/16 Due: 04/30/17